Berkeley Data Systems today announced the general availability of Mozy Pro, a business-oriented version of the company's popular consumer-oriented Mozy Remote Backup.
The hosted online backup service actually began without fanfare in December and currently has over 2,500 customers. Businesses can sign up for the service with no setup fee and no contract; payment is based on the number of computers covered and amount of storage required.
Mozy Pro offers automated continuous backup of essential files. As files change, it backs up the new versions - but it uploads only the changes, to save bandwidth. Single-instance storage means that identical files will be stored just once, and it's capable of backing up files even when other programs are holding them open. Backup data is encrypted during transmission and encrypted in storage, with an option to use a private encryption key. And file recovery, even recovery of earlier file versions, uses a simple Windows-based interface.
You pay $3.95 per month per covered computer for this service plus $0.50 per month per gigabyte of storage. The storage charge is based on original file size - there's no extra cost for storing earlier file versions. Storing 2GB of data would cost $5.95 per month; 20GB would cost $13.95 per month. According to BDS, competitor EVault Small Business Edition would cost $85 per month for 2GB and $300 per month for 20GB. BDS expects Mozy Pro and OEM sales to outpace the still-popular consumer-based Mozy Remote Backup by the end of this year.
Copyright 2007 by Ziff Davis Media, Distributed by United Press International
Related stories:
BDS Offers Unlimited Online Backup for Macs
The Mac Mozy beta service provides unlimited, secure backup of Mac-based digital media content, including iTunes and iPhoto collections.
VMware shares plunge on CEO change, slowing growth
(AP) -- VMware Inc. abruptly replaced co-founder Diane Greene as chief executive Tuesday and lowered its sales outlook, triggering alarms that pounded the business software maker's shares to their lowest depths since the company's lucrative public offering 11 months ago.
New logic: the attraction of magnetic computation
European researchers are the first to demonstrate functional components that exploit the magnetic properties of electrons to perform logic operations. Compatible with existing microtechnology, the new approach heralds the next era of faster, smaller and more efficient electronics.
Buzz mounts on 3G iPhone as Apple CEO sets appearance
Apple's top executive addresses an industry conference Monday, amid buzzing around the world that the company could announce the next generation of its blockbuster mobile iPhone.
A Great Lakes mystery: The case of the disappearing species
Throughout the overlooked depths of Lake Michigan and other Great Lakes, a small but important animal is rapidly disappearing. Until recently, the animal - a shrimplike, energy-dense creature called Diporeia - was a major food source for commercially important species like lake whitefish and many prey fish upon which salmon, trout and walleye rely.
World’s First Two-in-one Server Blade Joins HP Portfolio for Powering 'Scale-out' Computing Environments
HP today announced the world’s first two-in-one server blade, which offers customers with scale-out environments improved data center performance, reduced floor space and lower power usage.
Scientists remove thousands of aspens to glimpse forest's future
Armed with chainsaws and pry bars, University of Michigan researchers and their colleagues recently hastened the end for nearly 7,000 mature aspen and birch trees in a large-scale, long-term experiment to glimpse the Great Lakes region's future forests. A band of bark was stripped from each tree to kill it without cutting it down.
Gene therapy slows progression of fatal neurodegenerative disease in children
Gene therapy to replace the faulty CLN2 gene, which causes a neurodegenerative disease that is fatal by age 8-12 years, was able to slow significantly the rate of neurologic decline in treated children, according to a paper published online ahead of print in the May 2008 issue (Vol. 19 No. 5) of
Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.